Crossref journal-article
Ovid Technologies (Wolters Kluwer Health)
Circulation Research (276)
Abstract

AbstractConsiderable controversy surrounds the role of protein kinase C (PKC) in ischemic preconditioning (PC). Previous studies have used pharmacological agents and/or measured total myocardial PKC activity; however, no information is available regarding the effects of PC on individual isoforms in vivo. We performed a comprehensive evaluation (using Western immunoblotting) of the expression and subcellular distribution of all 11 currently known PKC isoforms in the heart of conscious rabbits subjected to four different ischemic PC protocols known to induce early and/or late PC (one, three, or six cycles of 4-minute coronary occlusion [4′O]/4-minute reperfusion [4′R]; four cycles of 5-minute occlusion [5′O]/10-minute reperfusion [10′R]). Ten PKC isoforms (α, β1/β2, γ, δ, ε, ζ, η, ι, λ, and μ) were found to be expressed in the rabbit heart. Quantitative immunoblotting demonstrated that as a subgroup, conventional PKCs (cPKCs) are more abundant than novel PKCs (nPKCs) (1445 versus 313 pg PKC/μg tissue protein, respectively) and that PKCα is the predominant isoform among the cPKCs (α, β1, β2, and γ), representing 51% of this subgroup, and PKCε is the most abundant among the nPKCs (δ, ε, ζ, and η), accounting for 62% of this subgroup. None of the ischemic PC protocols examined caused appreciable changes in total PKC activity, in the subcellular distribution of total PKC activity, or in the subcellular distribution of PKC isoforms α, β1/β2, γ, δ, ζ, ι, λ, and μ. In contrast, all PC protocols caused significant translocation of PKCε and PKCη isoforms from the cytosolic to the particulate fraction. The particulate fraction of PKCε increased in a dose-dependent fashion with the number of occlusion/reperfusion cycles performed, from 35±2% in the control group to 43±2% after one 4′O/5-minute reperfusion (5′R) cycle (P<.05), 52±2% after three cycles (P<.05 versus one cycle), and 66±3% after six cycles (P<.05 versus three cycles). The particulate fraction of PKCε also increased, after four 5′O/10′R cycles, to 50±3% (P<.05 versus control). In contrast to PKCε, the translocation of PKCη was independent of the number of occlusion/reperfusion cycles performed. The particulate fraction of PKCη increased from 67±3% in the control group to 84±2% after one 4′O/5′R cycle (P<.05), 84±2% after three 4′O/4′R cycles (P<.05), 86±3% after six 4′O/4′R cycles (P<.05), and 83±2% after four 5′O/10′R cycles (P<.05). When expressed as a percentage of control values, the increases in the particulate fraction of isoform ε were greater than those of isoform η. The effects of 4′O without reperfusion were similar to those of one cycle of 4′O/5′R, indicating that 5′R did not attenuate isoform translocation. This is the first study to demonstrate PKC translocation after ischemic PC in vivo. The results indicate that in the conscious rabbit, ischemic PC causes selective translocation of the ε and η isoforms without demonstrable changes in total myocardial PKC activity, implying that measurements of total PKC activity are not sufficiently sensitive to detect the involvement of PKC in PC. The results are consistent with the concept that the ε and η isozymes play an important role in the genesis of ischemic PC in the conscious rabbit.

Bibliography

Ping, P., Zhang, J., Qiu, Y., Tang, X.-L., Manchikalapudi, S., Cao, X., & Bolli, R. (1997). Ischemic Preconditioning Induces Selective Translocation of Protein Kinase C Isoforms ε and η in the Heart of Conscious Rabbits Without Subcellular Redistribution of Total Protein Kinase C Activity. Circulation Research, 81(3), 404–414.

Authors 7
  1. Peipei Ping (first)
  2. Jun Zhang (additional)
  3. Yumin Qiu (additional)
  4. Xian-Liang Tang (additional)
  5. Srinivas Manchikalapudi (additional)
  6. Xinan Cao (additional)
  7. Roberto Bolli (additional)
References 59 Referenced 338
  1. 10.1161/01.CIR.74.5.1124
  2. 10.1007/BF00053555
  3. Van Winkle DM, Thornton JD, Downey DM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis. 1991;2:613-619. / Coron Artery Dis (1991)
  4. 10.1016/1050-1738(92)90045-T
  5. 10.1161/res.74.5.8156647
  6. 10.1016/S0008-6363(96)88636-6
  7. 10.1097/00045415-199505000-00003
  8. 10.1007/BF00795364
  9. 10.1161/res.72.6.8495557
  10. 10.1161/01.CIR.88.3.1264
  11. 10.1172/JCI117667
  12. Qiu Y Maldonado C Tang X-L Bolli R. Late preconditioning against myocardial stunning in conscious rabbits. Circulation. 1995;92(suppl I):I-715. Abstract.
  13. Vegh A, Kaszala K, Papp JG, Parratt JR. Delayed myocardial protection by pacing-induced preconditioning: a possible role for bradykinin. Br J Pharmacol. 1995;116:288P. Abstract. / Br J Pharmacol (1995)
  14. 10.1172/JCI118449
  15. 10.1161/res.79.3.424
  16. Qiu Y Tang X Rizvi A Machikalapudi S Maldonado C Teschner S Bolli R. Protein kinase C mediates late preconditioning against myocardial stunning in conscious rabbits. Circulation. 1996;94(suppl I):I-184. Abstract.
  17. Teschner S Qiu Y Tang X Maldonado C Rizvi A Machikalapudi S Bagri H Jadoon A Bolli R. Late preconditioning against myocardial stunning in conscious rabbits: a dose-related or an all-or-none phenomenon? Circulation. 1996;94(suppl I):I-423. Abstract.
  18. Maldonado C Qiu Y Tang XL Cohen MV Manchikalapudi S Auchampach J Bolli R. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol. In press.
  19. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266:H1145-H1152. / Am J Physiol (1994)
  20. 10.1006/jmcc.1994.1078
  21. 10.1161/res.75.3.7914839
  22. 10.1007/BF00877409
  23. 10.1111/j.1476-5381.1995.tb15866.x
  24. 10.1161/res.75.3.8062429
  25. 10.1152/ajpheart.1995.268.1.H426
  26. 10.1161/res.76.1.73
  27. 10.1093/cvr/28.1.72
  28. 10.1161/res.77.5.1030
  29. Ikonomidis JS Shirai T Weisel RD Derylo B Rao V Whiteside CI Mickle DA Li RK. ‘Ischemic’ or adenosine preconditioning of human ventricular cardiomyocytes is protein kinase C dependent. Circulation. 1995;92(suppl I):I-12. Abstract.
  30. 10.1093/cvr/28.11.1700
  31. Ikonomidis JS, Shirai T, Weisel RD, Rao V, Mickle DAG, Li RK. Signal transduction in human cardiomyocyte preconditioning.J Moll Cell Cardiol. 1995;27:A-40. Abstract. / J Moll Cell Cardiol (1995)
  32. Strasser RH Braun M Schon SH Kempkes A Ihi-Vahl R Marquetant R. Two distinct mechanisms induce a subtype-selective activation of protein kinase C in acute myocardial ischemia. J Am Coll Cardiol. 1996;292A:783-1. Abstract. (10.1016/S0735-1097(96)82063-8)
  33. Strasser R Oehl U Herzog N Rothele J Simonis G Wolfgang K. Ischemic preconditioning fails to promote a repetitive translocation of protein kinase C. Circulation. 1996;94(suppl I):I-660. Abstract.
  34. Gray MO Mochly-Rosen D Honbo NY Karliner JS. Isoform-specific activation of protein kinase C in a rat cardiac myocyte model of ischemic preconditioning. Circulation. 1995;92(suppl I):I-137. Abstract.
  35. 10.1161/circ.92.6.1546
  36. Simkhovich BZ Przyklenk K Hale SL Kloner RA. Subcellular distribution of protein kinase C is not altered by brief preconditioning ischemia in rabbit myocardium. Circulation. 1995;92(suppl I):I-137. Abstract. (10.1161/01.CIR.92.6.1546)
  37. Galinanes M Sutherland FJ Brooks G Hearse DJ. Temporal distribution of protein kinase C during ischemia and preconditioning: is cytosol to membrane translocation (activation) involved? Circulation. 1995;92(suppl I):I-137. Abstract.
  38. 10.1161/res.79.3.407
  39. Vogt A Barancik M Weihrauch D Arras M Podzuweit T Schaper W. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo. Circulation. 1994;90(suppl I):I-647. Abstract.
  40. 10.1161/res.79.2.153
  41. 10.1006/jmcc.1996.0138
  42. 10.1161/res.81.1.42
  43. 10.1161/res.77.3.611
  44. 10.1161/res.69.3.1873868
  45. 10.1172/JCI116608
  46. 10.1161/res.80.6.800
  47. 10.1161/res.47.1.7379260
  48. 10.1161/res.72.4.8443867
  49. 10.1016/0014-5793(91)80989-G
  50. 10.1016/S0021-9258(17)38806-3
  51. 10.1161/res.79.3.388
  52. 10.1152/ajpcell.1991.260.3.C635
  53. 10.1161/res.78.1.161
  54. 10.1016/S0021-9258(18)98697-7
  55. Kazanietz MG, Areces LB, Bahador A, Mischak H, Goodnight J, Mushinski JF, Blumberg PM. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol Pharmacol. 1993;44:298-307. (10.1016/S0026-895X(25)13163-5) / Mol Pharmacol (1993)
  56. 10.1016/0968-0004(94)90038-8
  57. 10.1016/S0021-9258(19)39114-8
  58. 10.1016/0014-5793(89)80160-7
  59. 10.1161/res.70.6.1315640
Dates
Type When
Created 13 years, 2 months ago (June 11, 2012, 8:47 p.m.)
Deposited 5 months ago (March 30, 2025, 5:14 p.m.)
Indexed 3 months ago (June 2, 2025, 11:30 a.m.)
Issued 28 years ago (Sept. 1, 1997)
Published 28 years ago (Sept. 1, 1997)
Published Print 28 years ago (Sept. 1, 1997)
Funders 0

None

@article{Ping_1997, title={Ischemic Preconditioning Induces Selective Translocation of Protein Kinase C Isoforms ε and η in the Heart of Conscious Rabbits Without Subcellular Redistribution of Total Protein Kinase C Activity}, volume={81}, ISSN={1524-4571}, url={http://dx.doi.org/10.1161/01.res.81.3.404}, DOI={10.1161/01.res.81.3.404}, number={3}, journal={Circulation Research}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Ping, Peipei and Zhang, Jun and Qiu, Yumin and Tang, Xian-Liang and Manchikalapudi, Srinivas and Cao, Xinan and Bolli, Roberto}, year={1997}, month=sep, pages={404–414} }